Literature DB >> 3566113

Remaining indications for vagotomy with drainage or antrectomy in duodenal ulcer.

A C Steger, R B Galland, J Spencer.   

Abstract

Proximal gastric vagotomy (PGV) consists of denervation of the body and fundus of the stomach, the antral nerve supply being left intact. It has a low operative morbidity and mortality and there are few postvagotomy side effects. However, the recurrent ulcer rate may be higher than with other operations for duodenal ulcer. Nevertheless it is usually easier to treat post-PGV recurrence than the complications of other gastric acid lowering operations. This study defines those patients in whom we have not performed a PGV. Of 110 operations for duodenal ulcer since 1980, 70 were PGVs while 40 consisted of truncal or selective vagotomy combined either with a drainage procedure or antrectomy. It is our practice not to perform a PGV in those patients with prepyloric ulcers, pyloric stenosis, bleeding or perforated ulcers and recurrent ulcers.

Entities:  

Mesh:

Year:  1987        PMID: 3566113      PMCID: PMC2498431     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  7 in total

1.  Duodenoplasty with proximal gastric vagotomy.

Authors:  T Kennedy
Journal:  Ann R Coll Surg Engl       Date:  1976-03       Impact factor: 1.891

2.  Highly selective vagotomy without a drainage procedure in the treatment of haemorrhage, perforation, and pyloric stenosis due to peptic ulcer.

Authors:  D Johnston; P J Lyndon; R B Smith; C S Humphrey
Journal:  Br J Surg       Date:  1973-10       Impact factor: 6.939

3.  The four to eight year results of the Sheffield trial of elective duodenal ulcer surgery--highly selective or truncal vagotomy?

Authors:  C J Stoddard; A G Johnson; H L Duthie
Journal:  Br J Surg       Date:  1984-10       Impact factor: 6.939

4.  Prospective randomized multicentre trial of proximal gastric vagotomy or truncal vagotomy and antrectomy for chronic duodenal ulcer: results after 5-7 years.

Authors:  B C De Vries; M E Schattenkerk; E E Smith; J Spencer; D S Jackson; J Alexander-Williams; N J Dorricott
Journal:  Br J Surg       Date:  1983-12       Impact factor: 6.939

5.  The Aarhus County vagotomy trial. II. An interim report on reduction in acid secretion and ulcer recurrence rate following parietal cell vagotomy and selective gastric vagotomy.

Authors:  D Andersen; H Høstrup; E Amdrup
Journal:  World J Surg       Date:  1978-01       Impact factor: 3.352

6.  Prospective randomized multicentre trial of proximal gastric vagotomy or truncal vagotomy and antrectomy for chronic duodenal ulcer: interim results.

Authors:  N J Dorricott; A R Mcneish; J Alexander-Williams; C M Royston; W M Cooke; C J Spencer; B C De Vries; H Muller
Journal:  Br J Surg       Date:  1978-03       Impact factor: 6.939

7.  Cimetidine or parietal-cell vagotomy in patients with juxtapyloric ulcers.

Authors:  M Ström; G Bodemar; J Lindhagen; R Sjödahl; A Walan
Journal:  Lancet       Date:  1984-10-20       Impact factor: 79.321

  7 in total
  1 in total

1.  Surgeons' attitudes to the operative management of duodenal ulcer perforation and haemorrhage.

Authors:  M D Stringer; A E Cameron
Journal:  Ann R Coll Surg Engl       Date:  1988-07       Impact factor: 1.891

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.